News for hackers. Stuff that matters.
Re:Anthropic hits $2T in Nasdaq debut by seizethecheese on Thursday November 19, 2026 @04:20PM (#50566533)
> the bottleneck in drug discovery is not the design-part, but the trials.

You said the above to dismiss that Claude models could help with progress on cancer. My point is that if trials are the scarce thing, making sure the trials are on the right candidates is clearly important. I don't have an opinion on whether Claude can help now, but do believe at some point it can help.

There are no comments on this comment yet.